Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001596584-14-000001
Filing Date
2014-02-06
Accepted
2014-02-05 18:07:14
Documents
1
Effectiveness Date
2014-02-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8374
  Complete submission text file 0001596584-14-000001.txt   9402
Mailing Address 515 CONGRESS AVENUE, SUITE 1800 AUSTIN TX 78701
Business Address 515 CONGRESS AVENUE, SUITE 1800 AUSTIN TX 78701 15124220155
Lumos Pharma, Inc. (Filer) CIK: 0001596584 (see all company filings)

EIN.: 383830503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-211391 | Film No.: 14577363